Skip to main content
. Author manuscript; available in PMC: 2022 Dec 20.
Published in final edited form as: J Chem Inf Model. 2022 Oct 24;62(22):5607–5621. doi: 10.1021/acs.jcim.2c00999

Table 1.

IC50a and EC50b Values for the Original Zinc Compound and the MSR Derivative Compounds

compound IC50 (μM)a EC50 (μM)b
ZINC72424116 5.6 ± 0.38 (n = 4)c >50 (n = 3)
MSR01R 1.3 ± 0.33 (n = 5) >10 (n = 4)
MSR01S 1.0 ± 0.30 (n = 5) >10 (n = 4)
MSR02 2.0 ± 1.73 (n = 9) >10 (n = 5)
MSR03 1.6 ± 0.58 (n = 6) >10 (n = 5)d
a

The concentration of the test compound required to inhibit half-maximal adhesion of cells expressing human αVβ3 to immobilized fibrinogen.

b

The concentration of the test compound required to induce half-maximal exposure of the AP5 epitope.

c

Average value from five triplicate determinations using three different samples of compounds.

d

Studies performed with MSR03 prepared in DMSO. Repeat study of MSR03 dihydrochloride prepared in 1 M NaCl indicated that at 300 μM MSR03 did not increase AP5 binding above baseline and so its EC50 is >300 μM (n = 3).